Department of Radiology, Groupe Hospitalier Paris-Saint Joseph, Paris, France.
Department of Radiology and Nuclear Medicine, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Eur Radiol. 2023 Oct;33(10):7025-7033. doi: 10.1007/s00330-023-09701-1. Epub 2023 May 18.
To evaluate compliance with the available recommendations, we assessed the current clinical practice of imaging in the evaluation of multiple sclerosis (MS).
An online questionnaire was emailed to all members and affiliates. Information was gathered on applied MR imaging protocols, gadolinium-based contrast agents (GBCA) use and image analysis. We compared the survey results with the Magnetic Resonance Imaging in MS (MAGNIMS) recommendations considered as the reference standard.
A total of 428 entries were received from 44 countries. Of these, 82% of responders were neuroradiologists. 55% performed more than ten scans per week for MS imaging. The systematic use of 3 T is rare (18%). Over 90% follow specific protocol recommendations with 3D FLAIR, T2-weighted and DWI being the most frequently used sequences. Over 50% use SWI at initial diagnosis and 3D gradient-echo T1-weighted imaging is the most used MRI sequence for pre- and post-contrast imaging. Mismatches with recommendations were identified including the use of only one sagittal T2-weighted sequence for spinal cord imaging, the systematic use of GBCA at follow-up (over 30% of institutions), a delay time shorter than 5 min after GBCA administration (25%) and an inadequate follow-up duration in pediatric acute disseminated encephalomyelitis (80%). There is scarce use of automated software to compare images or to assess atrophy (13% and 7%). The proportions do not differ significantly between academic and non-academic institutions.
While current practice in MS imaging is rather homogeneous across Europe, our survey suggests that recommendations are only partially followed.
Hurdles were identified, mainly in the areas of GBCA use, spinal cord imaging, underuse of specific MRI sequences and monitoring strategies. This work will help radiologists to identify the mismatches between their own practices and the recommendations and act upon them.
• While current practice in MS imaging is rather homogeneous across Europe, our survey suggests that available recommendations are only partially followed. • Several hurdles have been identified through the survey that mainly lies in the areas of GBCA use, spinal cord imaging, underuse of specific MRI sequences and monitoring strategies.
为了评估现有建议的遵守情况,我们评估了目前在多发性硬化症(MS)评估中影像学的临床实践。
向所有成员和附属机构发送了在线问卷调查。收集了应用磁共振成像(MR)方案、钆基造影剂(GBCA)使用和图像分析的信息。我们将调查结果与作为参考标准的磁共振成像多发性硬化症(MAGNIMS)建议进行了比较。
共收到来自 44 个国家的 428 条回复。其中,82%的回复者为神经放射科医生。55%的人每周进行超过 10 次 MS 成像扫描。系统使用 3T 很少见(18%)。超过 90%的人遵循特定的方案建议,3D-FLAIR、T2 加权和 DWI 是最常用的序列。超过 50%的人在初始诊断时使用 SWI,3D 梯度回波 T1 加权成像则是用于对比前和对比后的最常用 MRI 序列。与建议不符的情况包括仅使用一个矢状 T2 加权序列进行脊髓成像、在随访中系统使用 GBCA(超过 30%的机构)、GBCA 给药后延迟时间短于 5 分钟(25%)以及儿科急性播散性脑脊髓炎的随访时间不足(80%)。很少有使用自动软件来比较图像或评估萎缩的情况(分别为 13%和 7%)。学术机构和非学术机构之间的比例没有显著差异。
尽管欧洲的 MS 成像的当前实践相当统一,但我们的调查表明,建议只是部分得到了遵循。
在 GBCA 的使用、脊髓成像、特定 MRI 序列和监测策略的应用不足等方面,存在一些障碍。这项工作将帮助放射科医生发现他们自己的实践与建议之间的不匹配之处,并采取相应措施。
尽管欧洲的 MS 成像的当前实践相当统一,但我们的调查表明,现有的建议只是部分得到了遵循。
通过调查发现了一些障碍,主要存在于 GBCA 的使用、脊髓成像、特定 MRI 序列和监测策略的应用不足等方面。